CRON•Cronos Group completed its acquisition of CanAdelaar for a base price of €57.5 million, subject to closing and post-closing adjustments. Additional cash payments will equal 0.5 times CanAdelaar’s Normalized EBITDA in each of 2026 and 2027.
Cronos Group completed its acquisition of CanAdelaar for a base price of €57.5 million, subject to closing and post-closing adjustments. Additional cash payments will equal 0.5 times CanAdelaar’s Normalized EBITDA in each of 2026 and 2027. The base price represents approximately 1.4 times net revenue and 2.9 times adjusted EBITDA, based on annualized first-half 2026 results.
The acquisition establishes a European operating platform through the market leader in the Netherlands’ adult-use cannabis pilot program.
